A5105839496- Gallbladder and Bile Duct Disorders
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Pancreatitis Pathology and Treatment
- Tracheal and airway disorders
- Appendicitis Diagnosis and Management
- Gastric Cancer Management and Outcomes
- Colorectal and Anal Carcinomas
- Radiomics and Machine Learning in Medical Imaging
- Gastrointestinal disorders and treatments
- Pediatric Hepatobiliary Diseases and Treatments
- Colorectal Cancer Screening and Detection
- Cancer Diagnosis and Treatment
- Renal Transplantation Outcomes and Treatments
- Congenital Heart Disease Studies
- Abdominal Trauma and Injuries
- Congenital Diaphragmatic Hernia Studies
- Renal and Vascular Pathologies
- Intraperitoneal and Appendiceal Malignancies
- Renal cell carcinoma treatment
- Transplantation: Methods and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Aortic aneurysm repair treatments
- Case Reports on Hematomas
- Hernia repair and management
Saint Mary's College
2025
Hospital Universitario Virgen de las Nieves
1999-2024
Instituto de Investigación Biosanitaria de Granada
2024
Complejo Hospitalario Universitario de Granada
2017
Abstract Background and Objectives: Colorectal cancer (CRC) is the third most occurring second cause of cancer-related deaths. Despite decades research fighting progression CRC development many therapeutic compounds, 5-year survival rate remains at around 64%, with worse prognosis advanced stages disease. The search for a fully efficacious treatment thus endures, in light these suboptimal prognostic figures. GEM144 novel compound that was recently synthesized as dual inhibitor DNA polymerase...
Multiple Renal Masses as Initial Manifestation of Wegener's GranulomatosisEduardo Ruiz Carazo1, Antonio Medina Benitez1, Genaro López Milena1, Jesús Rabaza Espigares1, Laura León2 and Belgica Marquez3Audio Available | Share
Mayo clinic classification (MCC) has been proposed in patients with autosomal dominant polycystic kidney disease (ADPKD) to identify who may experience a rapid decline of renal function. Our aim was validate this predictive model population from southern Spain.ADPKD measurements height-adjusted total volume (HtTKV) and baseline estimated glomerular filtration rate (eGFR) >30 mL/min/1.73 m2 were selected. Last eGFR Clinic (MC) equation bias accuracy studied. We also analyzed capacity MCC...
The incidence of malignant tumors in recipients renal allografts is higher than the general population. Renal cell carcinoma (RCC) accounts for 4.6% transplanted patients; them, only 10% are found kidneys. Transplantectomy has always been usual treatment. However, during last years, nephron-sparing surgery allograft more frequently done well-selected cases, and therefore dialysis can be avoided. We report case a 37-year-old female patient with transplant, diagnosed 4.5 cm tumor lower pole...
We report the case of a patient with acute exacerbation chronic pancreatitis and he suffered an atraumatic splenic rupture. Splenic rupture not associated trauma is rare entity that can occurs in normal spleen (spontaneous) or damaged (pathological). This may be local inflammatory processes, such as pancreatitis. Ultrasound non-invasive technique which used unstable patients. CT useful for making diagnosis extension patients hemodynamic stability. Atraumatic complication unusual disease...
Introduction: Telerobotic ultrasound has emerged as a promising technology in medicine, especially settings with limited medical access or lack of specialized personnel. However, there are very few studies evaluating its usefulness real‐world clinical practice. Objective: This study evaluates the abdominopelvic telerobotic practice setting. Methods: A prospective was performed cohort adult patients who underwent abdominal remote secondary hospital for suspected pelvic pathology. Examinations...
Los hematomas intramurales intestinales espontáneos son una causa altamente infrecuente del dolor abdominal agudo, pero es un diagnóstico probable en pacientes anticoagulados o con enfermedad hematológica de base. Si bien el tiempo medio presentación desde inicio la anticoagulación 24,4 meses, puede llegar a aparecer tan solo 10 días después instauración tratamiento. Sus hallazgos clínicos muy inespecíficos (p. ej. y náuseas), aunque no siempre, común que sean similares los cuadro...